I/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsMino-WrapI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Insidersinvested$26.5mMino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013I won't diluteshareholdersWe willhaveexclusivityWe expect tofinish theMino-Loktrial this yearWe intendto submita BLA in2H 2022I'm ashareholdermyselfI/ONTAKis our leadassetOnly biotechwith 2 Myron'son theleadershipteamHemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mNot manycompaniesthis size with2 late stageassetsMino-WrapI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Insidersinvested$26.5mMino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013I won't diluteshareholdersWe willhaveexclusivityWe expect tofinish theMino-Loktrial this yearWe intendto submita BLA in2H 2022I'm ashareholdermyselfI/ONTAKis our leadassetOnly biotechwith 2 Myron'son theleadershipteamHemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyAn actualiMSCupdate

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK's potential market is >$300m
  2. Not many companies this size with 2 late stage assets
  3. Mino-Wrap
  4. I/ONTAK was the best deal I ever made
  5. Our Halo-Lido trial will have final patient by end of 2022
  6. We will open up international sites for Mino-Lok trial
  7. There are no FDA approved drugs to treat hemorrhoids
  8. We have enough cash to go well into 2023
  9. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  10. Mino-Lok potential market >$1B
  11. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  12. Insiders invested $26.5m
  13. Mino-Lok is our lead asset
  14. Myron Holubiak and I founded a private company in 2013
  15. I won't dilute shareholders
  16. We will have exclusivity
  17. We expect to finish the Mino-Lok trial this year
  18. We intend to submit a BLA in 2H 2022
  19. I'm a shareholder myself
  20. I/ONTAK is our lead asset
  21. Only biotech with 2 Myron's on the leadership team
  22. Hemorrhoids is a $2B market
  23. We had a phase 2b trial with 100% efficacy
  24. An actual iMSC update